Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

IntroductionEpstein-Barr virus (EBV) is an oncogenic human herpesvirus associated with ~350,000 cases of lymphoid and epithelial malignancies every year, and is etiologically linked to infectious mononucleosis and multiple sclerosis. Despite four decades of research, no EBV vaccine candidate has yet...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Gabriela M. Escalante, Ivana G. Reidel, Lorraine Z. Mutsvunguma, Simeon Cua, Brenda A. Tello, Esther Rodriguez, Mafalda A. Farelo, Cloe Zimmerman, Murali Muniraju, He Li, Aparna N. Govindan, Michael K. Axthelm, Scott W. Wong, Javier Gordon Ogembo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-09-01
Серія:	Frontiers in Immunology
Предмети:	Epstein-Barr virus infectious mononucleosis cancer prophylactic vaccine glycoprotein neutralizing antibody
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1445209/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice

Схожі ресурси